Increasing opportunities for breast-conserving therapy in multiple ipsilateral breast cancer: Dutch nationwide study
British Journal of Surgery · 2024
DOI: 10.1093/bjs/znae229 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, 2024. Verfasst von Eva Heeling und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Mastectomy, Segmental, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Introduction
An increasing number of breast cancer patients undergo breast-conserving surgery (BCS), but multiple ipsilateral breast cancer (MIBC) is still considered a relative contraindication for breast conservation. This study provides an update on trends in the surgical management for MIBC over a 10-year period.
Methods
Nationwide data from the Netherlands Cancer Registration of all patients diagnosed with breast cancer between 2011 and 2021 were analysed. The primary outcomes of this study were the incidence of MIBC and the trend in breast surgery type among patients between 2011 and 2021. Secondary outcomes were the positive resection margin rates in patients treated with BCS, the proportion of patients requiring re-excision and overall survival.
Results
In total, 114 433 patients (83%) with unifocal breast cancer and 23 932 patients (17%) with MIBC were identified. The incidence of MIBC was stable (17%) over the years. Overall BCS rates, both primary and after neoadjuvant chemotherapy, increased in MIBC from 29% in 2011 to 41% in 2021. Re-excision was performed in 1348 patients (n = 8455, 16%). The 5-year OS estimate for patients with MIBC treated with BCS was 93%. The pathological complete response (pCR) in MIBC patients treated with neoadjuvant chemotherapy followed by mastectomy was 23%.
Conclusion
The breast conservation rate in MIBC has increased over the last decade. In addition, 23% of MIBC patients treated with neoadjuvant chemotherapy followed by mastectomy achieved a pCR. This suggests increasing opportunities for even more BCS in MIBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
- Department of Surgical Oncology, Diakonessenhuis, Utrecht, The Netherlands.
- Department of Surgical Oncology, Gelderse Vallei Hospital, Ede, The Netherlands.
- Department of Surgical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
- Department of Surgical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Zitieren
APA
Heeling, E., Volders, J. H., de Roos, W. K., van Eekeren, R. R. J. P., van der Ploeg, I. M. C., & Vrancken Peeters, M. T. F. D. (2024). Increasing opportunities for breast-conserving therapy in multiple ipsilateral breast cancer: Dutch nationwide study. British Journal of Surgery. https://doi.org/10.1093/bjs/znae229
Vancouver
Heeling E, Volders JH, de Roos WK, van Eekeren RRJP, van der Ploeg IMC, Vrancken Peeters MTFD. Increasing opportunities for breast-conserving therapy in multiple ipsilateral breast cancer: Dutch nationwide study. British Journal of Surgery. 2024. doi:10.1093/bjs/znae229
BibTeX
@article{Heeling2024,
author = {Heeling, Eva and Volders, José H and de Roos, Wilfred K and van Eekeren, Ramon R J P and van der Ploeg, Iris M C and Vrancken Peeters, Marie-Jeanne T F D},
title = {Increasing opportunities for breast-conserving therapy in multiple ipsilateral breast cancer: Dutch nationwide study},
journal = {British Journal of Surgery},
year = {2024},
doi = {10.1093/bjs/znae229}
}
EUVIMED